Biomarker Testing in Non-Small Cell Lung Cancer: To Move Forward With Quality

Clinical and Translational Oncology - Italy
doi 10.1007/s12094-012-0802-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Updates Regarding Biomarker Testing for Non–Small Cell Lung Cancer: Considerations From the National Lung Cancer Roundtable

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Non–small Cell Lung Cancer Predictive Biomarker Testing via Immunocytochemistry: Ways of Future Past?

Cancer cytopathology
Cancer ResearchOncology
2019English

Quality of Life in Patients With Non-Small Cell Lung Cancer

Vojnosanitetski Pregled
MedicinePharmacology
2017English

Hsa_circ_0033155: A Potential Novel Biomarker for Non‑small Cell Lung Cancer

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Biomarker Discovery and Identification From Non-Small Cell Lung Cancer Sera

Frontiers in Bioscience - Elite
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2011English

S100B as a Biomarker for Brain Metastases in Patients With Non‑small Cell Lung Cancer

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2020English

Non-Small Cell Lung Cancer

English

Alpha-Actinin 4 Is Associated With Cancer Cell Motility and Is a Potential Biomarker in Non–Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Quality-Of-Care Indicators for Non-Small Cell Lung Cancer

Cancer Control
MedicineOncologyHematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy